GAO study criticizes FDA’s record on postmarket decisionmaking
April 29, 2006
On a more serious note, in case you missed this, the Government Accounting Office just released a report this week analyzing FDA's effectiveness in postmarket drug safety decisionmaking, and factors that may have influenced it.
On a more serious note, in case you missed this, the Government Accounting Office just released a report this week analyzing FDA's effectiveness in postmarket drug safety decisionmaking, and factors that may have influenced it.
